Clinical Trials Browser

Phase 2 × NIH × dinaciclib × Clear all

NCT00937937 2026-05-29

Dinaciclib in Treating Patients With Stage IV Melanoma

Phase 2 Active not recruiting

72 enrolled 14 charts

Melanoma

NCT01096342 2014-06-18

Dinaciclib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Completed

16 enrolled 6 charts

Multiple Myeloma